FR2931678B1 - Utilisation du trilistane pour le traitement de la depression - Google Patents

Utilisation du trilistane pour le traitement de la depression

Info

Publication number
FR2931678B1
FR2931678B1 FR0802905A FR0802905A FR2931678B1 FR 2931678 B1 FR2931678 B1 FR 2931678B1 FR 0802905 A FR0802905 A FR 0802905A FR 0802905 A FR0802905 A FR 0802905A FR 2931678 B1 FR2931678 B1 FR 2931678B1
Authority
FR
France
Prior art keywords
trilistane
treatment
low pressure
pressure
low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0802905A
Other languages
English (en)
Other versions
FR2931678A1 (fr
Inventor
Jamal Temsamani
Claude Laruelle
Tanguy Maurice
Julie Espallergues
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CLL Pharma SA
Original Assignee
CLL Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CLL Pharma SA filed Critical CLL Pharma SA
Priority to FR0802905A priority Critical patent/FR2931678B1/fr
Priority to PCT/FR2009/000576 priority patent/WO2009153428A2/fr
Publication of FR2931678A1 publication Critical patent/FR2931678A1/fr
Application granted granted Critical
Publication of FR2931678B1 publication Critical patent/FR2931678B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0802905A 2008-05-27 2008-05-27 Utilisation du trilistane pour le traitement de la depression Expired - Fee Related FR2931678B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0802905A FR2931678B1 (fr) 2008-05-27 2008-05-27 Utilisation du trilistane pour le traitement de la depression
PCT/FR2009/000576 WO2009153428A2 (fr) 2008-05-27 2009-05-15 Utilisation du trilostane pour le traitement de la depression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0802905A FR2931678B1 (fr) 2008-05-27 2008-05-27 Utilisation du trilistane pour le traitement de la depression

Publications (2)

Publication Number Publication Date
FR2931678A1 FR2931678A1 (fr) 2009-12-04
FR2931678B1 true FR2931678B1 (fr) 2010-10-01

Family

ID=39865372

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0802905A Expired - Fee Related FR2931678B1 (fr) 2008-05-27 2008-05-27 Utilisation du trilistane pour le traitement de la depression

Country Status (2)

Country Link
FR (1) FR2931678B1 (fr)
WO (1) WO2009153428A2 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
US20030232798A1 (en) * 2001-06-12 2003-12-18 Yadon Arad Adrenal enzyme inhibitors
JP5544458B2 (ja) * 2005-07-12 2014-07-09 アンピオ ファーマシューティカルズ，インコーポレイテッド 疾病を治療するための医薬製品の製造においてトリロスタンｉｉｉを使用する方法及びトリロスタンｉｉｉを含む医薬製品
US20070078114A1 (en) * 2005-09-02 2007-04-05 Myriad Genetics, Incorporated Combination therapy for alzheimer's disease and other diseases

Also Published As

Publication number Publication date
WO2009153428A3 (fr) 2010-04-29
FR2931678A1 (fr) 2009-12-04
WO2009153428A2 (fr) 2009-12-23

Similar Documents

Publication Publication Date Title
FR2948016B1 (fr) Orthese pour le traitement de la rhizarthrose
FR2907011B1 (fr) Utilisation de la citrulline pour le traitement des etats de denutrition
FR2912833B1 (fr) Panneau pour le traitement acoustique
BRPI0906922A2 (pt) Válvula de alta pressão
FR2948687B1 (fr) Utilisation de microarn pour le traitement de pathologies respiratoires chroniques
FR2938202B1 (fr) Traitement de surface pour adhesion moleculaire
FR2923491B1 (fr) Utilisation de bacteries pour la production de sources de bioenergie
FR2928832B1 (fr) Orthese de poignet, destinee au traitement du syndrome du canal carpien
FR2951637B1 (fr) Table pour massages de personnes allongees ou assises.
BRPI1008666A2 (pt) dispositivo de alta pressão
FR2941591B1 (fr) Utilisation de la chitine pour la biofertilisation des cultures non-legumineuses
NO20091269L (no) Dynamisk flensklemme
FR2944969B1 (fr) Utilisation de n2o gazeux dans le traitement des douleurs chroniques
FR2902320B1 (fr) Utilisation de butylated hydroxyanisole pour le traitement de la canitie
FR2899128B1 (fr) Utilisation de filtres de deleucocytation pour la purification de defensines
FR2954124B1 (fr) Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee
FR2932101B1 (fr) Utilisation de supports soufres pour le reformage catalytique.
FR2962586B1 (fr) Panneau pour le traitement acoustique
BRPI1012139A2 (pt) balanceador de volume variado para purificação do sangue
FR2938762B1 (fr) Utilisation cosmetique de proteines de type dj-1 pour le traitement de la secheresse cutanee
FI8431U1 (fi) Kaavinlaite
FR2928153B1 (fr) Nouvel additif pour le traitement des aciers resulfures
FR2910813B1 (fr) Nouvelle utilisation therapeutique pour le traitement des leucemies
ES1069414Y (es) Manometro
FR2931678B1 (fr) Utilisation du trilistane pour le traitement de la depression

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140131